Analysis of MS Patients Who Have Had Greater Than 60 Infusions of Natalizumab
Condition: Multiple Sclerosis Intervention: Drug: Natalizumab Sponsor: Multiple Sclerosis Center of Northeastern New York Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials